AML Prognosis Improved With Promising Therapy Combinations

HOUSTON—The prognosis for older patients with acute myeloid leukemia (AML) has remained dismal, even after treatment with a hypomethylating agent. Standard curative treatment for AML, which is primarily a disease of older adults with a median age of 68 years at...

Some IBD Patients Have Increased Skin Cancer Risk

Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.

Houston, Miami VAMCs Participate in Tocilizumab Trial

HOUSTON—The Michael E. DeBakey VAMC in Houston and the Bruce W. Carter VAMC in Miami are among nearly 70 locations across the world participating in a randomized double-blind clinical trial of an immunomodulator, tocilizumab, for patients with severe pneumonia...

AI/AN Patients Faced Diabetes Care Disparities Within MHS

BETHESDA, MD—Readmissions following hospitalization for diabetes often occur and are more common in minority patients, who experience greater rates of complications and lower quality healthcare compared to white patients. A study in Military Medicine examined...